Revolution Medicines, Inc. (RVMD)
150.20
+2.99
(+2.03%)
USD |
NASDAQ |
May 06, 13:28
Revolution Medicines EPS Diluted (Quarterly) : -1.855 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -0.2945 |
| AtriCure, Inc. | 0.0366 |
| Eli Lilly & Co. | 8.255 |
| Travere Therapeutics, Inc. | -0.3984 |
| Kymera Therapeutics, Inc. | -0.7098 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -364.89M |
| Total Expenses (Quarterly) | 364.89M |
| Enterprise Value | 27.57B |
| Earnings Yield | -3.94% |
| Normalized Earnings Yield | -3.902 |